Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
| ChEMBL ligand: CHEMBL3639728 (Plx-5622, PLX-5622, PLX5622) |
|---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
| DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
|---|---|---|---|---|---|---|---|---|
| activin A receptor type 1B/Activin receptor type-1B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5310] [GtoPdb: 1787] [UniProtKB: P36896] | ||||||||
| ChEMBL | Inhibition of ACVR1B (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| ALK receptor tyrosine kinase/ALK tyrosine kinase receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4247] [GtoPdb: 1839] [UniProtKB: Q9UM73] | ||||||||
| ChEMBL | Inhibition of ALK (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| protein kinase AMP-activated non-catalytic subunit gamma 1/protein kinase AMP-activated catalytic subunit alpha 1/protein kinase AMP-activated non-catalytic subunit beta 1/AMP-activated protein kinase (AMPK) alpha-1/beta-1/gamma-1 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2111345] [GtoPdb: 1545, 1541, 1543] [UniProtKB: P54619, Q13131, Q9Y478] | ||||||||
| ChEMBL | Inhibition of AMPK_A1/B1/G1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| protein kinase AMP-activated non-catalytic subunit gamma 1/protein kinase AMP-activated catalytic subunit alpha 2/protein kinase AMP-activated non-catalytic subunit beta 1/AMPK alpha2/beta1/gamma1 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL3038455] [GtoPdb: 1545, 1542, 1543] [UniProtKB: P54619, P54646, Q9Y478] | ||||||||
| ChEMBL | Inhibition of AMPK_A2/B1/G1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| TEK receptor tyrosine kinase/Angiopoietin-1 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4128] [GtoPdb: 1842] [UniProtKB: Q02763] | ||||||||
| ChEMBL | Inhibition of TEK (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| aurora kinase A/Aurora kinase A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4722] [GtoPdb: 1936] [UniProtKB: O14965] | ||||||||
| ChEMBL | Inhibition of AURKA (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| aurora kinase B/Aurora kinase B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2185] [GtoPdb: 1937] [UniProtKB: Q96GD4] | ||||||||
| ChEMBL | Inhibition of AURKB (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| aurora kinase C/Aurora kinase C in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3935] [GtoPdb: 1938] [UniProtKB: Q9UQB9] | ||||||||
| ChEMBL | Selectivity interaction (SelectScreen (Invitrogen, enzymatic assay with 100 µM ATP)) EUB0000697a AURKC | B | 6 | pIC50 | 1000 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
| ChEMBL | Inhibition of AURKC (unknown origin) | B | 6 | pIC50 | 1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| neurotrophic receptor tyrosine kinase 2/BDNF/NT-3 growth factors receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4898] [GtoPdb: 1818] [UniProtKB: Q16620] | ||||||||
| ChEMBL | Inhibition of NTRK2 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| beta adrenergic receptor kinase 1/Beta-adrenergic receptor kinase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4079] [GtoPdb: 1466] [UniProtKB: P25098] | ||||||||
| ChEMBL | Inhibition of ADRBK1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| calcium/calmodulin dependent protein kinase I/Calcium/calmodulin-dependent protein kinase type 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2493] [GtoPdb: 1952] [UniProtKB: Q14012] | ||||||||
| ChEMBL | Inhibition of CAMK1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| calcium/calmodulin dependent protein kinase ID/Calcium/calmodulin-dependent protein kinase type 1D in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5073] [GtoPdb: 1953] [UniProtKB: Q8IU85] | ||||||||
| ChEMBL | Inhibition of CAMK1D (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| calcium/calmodulin-dependent protein kinase II alpha subunit/Calcium/calmodulin-dependent protein kinase type II subunit alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4147] [GtoPdb: 1555] [UniProtKB: Q9UQM7] | ||||||||
| ChEMBL | Inhibition of CAMK2A (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| calcium/calmodulin-dependent protein kinase II beta subunit/Calcium/calmodulin-dependent protein kinase type II subunit beta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4121] [GtoPdb: 1556] [UniProtKB: Q13554] | ||||||||
| ChEMBL | Inhibition of CAMK2B (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| calcium/calmodulin-dependent protein kinase II delta subunit/Calcium/calmodulin-dependent protein kinase type II subunit delta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2801] [GtoPdb: 1558] [UniProtKB: Q13557] | ||||||||
| ChEMBL | Inhibition of CAMK2D (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| calcium/calmodulin dependent protein kinase IV/Calcium/calmodulin-dependent protein kinase type IV in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2494] [GtoPdb: 1955] [UniProtKB: Q16566] | ||||||||
| ChEMBL | Inhibition of CAMK4 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| protein kinase, cAMP-dependent, catalytic, alpha subunit/cAMP-dependent protein kinase catalytic subunit alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4101] [GtoPdb: 1476] [UniProtKB: P17612] | ||||||||
| ChEMBL | Inhibition of PRKACA (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| protein kinase X-linked/cAMP-dependent protein kinase catalytic subunit PRKX in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5818] [GtoPdb: 2175] [UniProtKB: P51817] | ||||||||
| ChEMBL | Inhibition of PRKX (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| casein kinase 1 alpha 1/Casein kinase I isoform alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2793] [GtoPdb: 1995] [UniProtKB: P48729] | ||||||||
| ChEMBL | Inhibition of CSNK1A1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| casein kinase 1 delta/Casein kinase I isoform delta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2828] [GtoPdb: 1997] [UniProtKB: P48730] | ||||||||
| ChEMBL | Inhibition of CSNK1D (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| casein kinase 1 epsilon/Casein kinase I isoform epsilon in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4937] [GtoPdb: 1998] [UniProtKB: P49674] | ||||||||
| ChEMBL | Inhibition of CSNK1E (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| casein kinase 1 gamma 1/Casein kinase I isoform gamma-1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2426] [GtoPdb: 1999] [UniProtKB: Q9HCP0] | ||||||||
| ChEMBL | Inhibition of CSNK1G1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| casein kinase 1 gamma 2/Casein kinase I isoform gamma-2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2543] [GtoPdb: 2000] [UniProtKB: P78368] | ||||||||
| ChEMBL | Inhibition of CSNK1G2 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| casein kinase 1 gamma 3/Casein kinase I isoform gamma-3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5084] [GtoPdb: 2001] [UniProtKB: Q9Y6M4] | ||||||||
| ChEMBL | Inhibition of CSNK1G3 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| casein kinase 2, alpha 1 polypeptide subunit/Casein kinase II subunit alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3629] [GtoPdb: 1549] [UniProtKB: P68400] | ||||||||
| ChEMBL | Inhibition of CSNK2A1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| casein kinase 2, alpha prime polypeptide subunit/Casein kinase II subunit alpha` in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4070] [GtoPdb: 1550] [UniProtKB: P19784] | ||||||||
| ChEMBL | Inhibition of CSNK2A2 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| cyclin dependent kinase 7/CDK7/Cyclin H/MNAT1 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL3038473] [GtoPdb: 1979] [UniProtKB: P50613, P51946, P51948] | ||||||||
| ChEMBL | Inhibition of CDK7/CyclinH/MNAT1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| cyclin dependent kinase 9/CDK9/cyclin T1 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2111389] [GtoPdb: 1981] [UniProtKB: O60563, P50750] | ||||||||
| ChEMBL | Inhibition of CDK9/CyclinT1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| Protein kinase G (PKG) 1/cGMP-dependent protein kinase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4273] [GtoPdb: 1492] [UniProtKB: Q13976] | ||||||||
| ChEMBL | Inhibition of PRKG1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| Protein kinase G (PKG) 2/cGMP-dependent protein kinase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2896] [GtoPdb: 1493] [UniProtKB: Q13237] | ||||||||
| ChEMBL | Inhibition of PRKG2 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| cyclin dependent kinase 1/Cyclin-dependent kinase 1/cyclin B1 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL1907602] [GtoPdb: 1961] [UniProtKB: P06493, P14635] | ||||||||
| ChEMBL | Inhibition of CDK1/CyclinB (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| cyclin dependent kinase 5/Cyclin-dependent kinase 5/CDK5 activator 1 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL1907600] [GtoPdb: 1977] [UniProtKB: Q00535, Q15078] | ||||||||
| ChEMBL | Inhibition of CDK5_p25 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| ChEMBL | Inhibition of CDK5_p35 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| CYP1A2/Cytochrome P450 1A2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3356] [GtoPdb: 1319] [UniProtKB: P05177] | ||||||||
| ChEMBL | Inhibition Enzyme Assay: CYP (Cytochrome P450) enzymes are the major drug metabolizing enzymes present in the liver. The inhibition of CYP enzyme activity (IC50) for each of CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4(BFC) and CYP3A4(BQ) is determined for compounds, where inhibition of metabolism of a known substrate leads to a decrease in the fluorescence of the metabolized product. The fluorescence of the product is monitored as a function of compound concentration.Compounds are dissolved in DMSO to a concentration of 100 mM. These are diluted 1 uL into 82 uL of acetonitrile. An 11 uL aliquot of this solution is then added to 204 uL of cofactor mix (1.3% NADPH Regeneration system Solution A, 1.04% NADPH Regeneration system Solution B from BD Biosciences, 5% acetonitrile and 0.05% DMSO). These are then serially diluted 1:1 (160 uL to 160 uL co-factor mix) for a total of 10 points. A 10 uL aliquot of this final mixture is dispensed into 384 well assay plates. | B | 5 | pIC50 | >10000 | nM | IC50 | US-9096593-B2. Compounds and methods for kinase modulation, and indications therefor (2015) |
| CYP2C19/Cytochrome P450 2C19 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3622] [GtoPdb: 1328] [UniProtKB: P33261] | ||||||||
| ChEMBL | Inhibition Enzyme Assay: CYP (Cytochrome P450) enzymes are the major drug metabolizing enzymes present in the liver. The inhibition of CYP enzyme activity (IC50) for each of CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4(BFC) and CYP3A4(BQ) is determined for compounds, where inhibition of metabolism of a known substrate leads to a decrease in the fluorescence of the metabolized product. The fluorescence of the product is monitored as a function of compound concentration.Compounds are dissolved in DMSO to a concentration of 100 mM. These are diluted 1 uL into 82 uL of acetonitrile. An 11 uL aliquot of this solution is then added to 204 uL of cofactor mix (1.3% NADPH Regeneration system Solution A, 1.04% NADPH Regeneration system Solution B from BD Biosciences, 5% acetonitrile and 0.05% DMSO). These are then serially diluted 1:1 (160 uL to 160 uL co-factor mix) for a total of 10 points. A 10 uL aliquot of this final mixture is dispensed into 384 well assay plates. | B | 5.3 | pIC50 | 5000 | nM | IC50 | US-9096593-B2. Compounds and methods for kinase modulation, and indications therefor (2015) |
| CYP2C9/Cytochrome P450 2C9 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3397] [GtoPdb: 1326] [UniProtKB: P11712] | ||||||||
| ChEMBL | Inhibition Enzyme Assay: CYP (Cytochrome P450) enzymes are the major drug metabolizing enzymes present in the liver. The inhibition of CYP enzyme activity (IC50) for each of CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4(BFC) and CYP3A4(BQ) is determined for compounds, where inhibition of metabolism of a known substrate leads to a decrease in the fluorescence of the metabolized product. The fluorescence of the product is monitored as a function of compound concentration.Compounds are dissolved in DMSO to a concentration of 100 mM. These are diluted 1 uL into 82 uL of acetonitrile. An 11 uL aliquot of this solution is then added to 204 uL of cofactor mix (1.3% NADPH Regeneration system Solution A, 1.04% NADPH Regeneration system Solution B from BD Biosciences, 5% acetonitrile and 0.05% DMSO). These are then serially diluted 1:1 (160 uL to 160 uL co-factor mix) for a total of 10 points. A 10 uL aliquot of this final mixture is dispensed into 384 well assay plates. | B | 5.3 | pIC50 | 5000 | nM | IC50 | US-9096593-B2. Compounds and methods for kinase modulation, and indications therefor (2015) |
| CYP2D6/Cytochrome P450 2D6 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL289] [GtoPdb: 1329] [UniProtKB: P10635] | ||||||||
| ChEMBL | Inhibition Enzyme Assay: CYP (Cytochrome P450) enzymes are the major drug metabolizing enzymes present in the liver. The inhibition of CYP enzyme activity (IC50) for each of CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4(BFC) and CYP3A4(BQ) is determined for compounds, where inhibition of metabolism of a known substrate leads to a decrease in the fluorescence of the metabolized product. The fluorescence of the product is monitored as a function of compound concentration.Compounds are dissolved in DMSO to a concentration of 100 mM. These are diluted 1 uL into 82 uL of acetonitrile. An 11 uL aliquot of this solution is then added to 204 uL of cofactor mix (1.3% NADPH Regeneration system Solution A, 1.04% NADPH Regeneration system Solution B from BD Biosciences, 5% acetonitrile and 0.05% DMSO). These are then serially diluted 1:1 (160 uL to 160 uL co-factor mix) for a total of 10 points. A 10 uL aliquot of this final mixture is dispensed into 384 well assay plates. | B | 5 | pIC50 | >10000 | nM | IC50 | US-9096593-B2. Compounds and methods for kinase modulation, and indications therefor (2015) |
| ChEMBL | Inhibition Enzyme Assay: CYP (Cytochrome P450) enzymes are the major drug metabolizing enzymes present in the liver. The inhibition of CYP enzyme activity (IC50) for each of CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4(BFC) and CYP3A4(BQ) is determined for compounds, where inhibition of metabolism of a known substrate leads to a decrease in the fluorescence of the metabolized product. The fluorescence of the product is monitored as a function of compound concentration.Compounds are dissolved in DMSO to a concentration of 100 mM. These are diluted 1 uL into 82 uL of acetonitrile. An 11 uL aliquot of this solution is then added to 204 uL of cofactor mix (1.3% NADPH Regeneration system Solution A, 1.04% NADPH Regeneration system Solution B from BD Biosciences, 5% acetonitrile and 0.05% DMSO). These are then serially diluted 1:1 (160 uL to 160 uL co-factor mix) for a total of 10 points. A 10 uL aliquot of this final mixture is dispensed into 384 well assay plates. | B | 5 | pIC50 | >10000 | nM | IC50 | US-9096593-B2. Compounds and methods for kinase modulation, and indications therefor (2015) |
| CYP3A4/Cytochrome P450 3A4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL340] [GtoPdb: 1337] [UniProtKB: P08684] | ||||||||
| ChEMBL | Inhibition Enzyme Assay: CYP (Cytochrome P450) enzymes are the major drug metabolizing enzymes present in the liver. The inhibition of CYP enzyme activity (IC50) for each of CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4(BFC) and CYP3A4(BQ) is determined for compounds, where inhibition of metabolism of a known substrate leads to a decrease in the fluorescence of the metabolized product. The fluorescence of the product is monitored as a function of compound concentration.Compounds are dissolved in DMSO to a concentration of 100 mM. These are diluted 1 uL into 82 uL of acetonitrile. An 11 uL aliquot of this solution is then added to 204 uL of cofactor mix (1.3% NADPH Regeneration system Solution A, 1.04% NADPH Regeneration system Solution B from BD Biosciences, 5% acetonitrile and 0.05% DMSO). These are then serially diluted 1:1 (160 uL to 160 uL co-factor mix) for a total of 10 points. A 10 uL aliquot of this final mixture is dispensed into 384 well assay plates. | B | 5 | pIC50 | >10000 | nM | IC50 | US-9096593-B2. Compounds and methods for kinase modulation, and indications therefor (2015) |
| ChEMBL | Inhibition Enzyme Assay: CYP (Cytochrome P450) enzymes are the major drug metabolizing enzymes present in the liver. The inhibition of CYP enzyme activity (IC50) for each of CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4(BFC) and CYP3A4(BQ) is determined for compounds, where inhibition of metabolism of a known substrate leads to a decrease in the fluorescence of the metabolized product. The fluorescence of the product is monitored as a function of compound concentration.Compounds are dissolved in DMSO to a concentration of 100 mM. These are diluted 1 uL into 82 uL of acetonitrile. An 11 uL aliquot of this solution is then added to 204 uL of cofactor mix (1.3% NADPH Regeneration system Solution A, 1.04% NADPH Regeneration system Solution B from BD Biosciences, 5% acetonitrile and 0.05% DMSO). These are then serially diluted 1:1 (160 uL to 160 uL co-factor mix) for a total of 10 points. A 10 uL aliquot of this final mixture is dispensed into 384 well assay plates. | B | 5.3 | pIC50 | 5000 | nM | IC50 | US-9096593-B2. Compounds and methods for kinase modulation, and indications therefor (2015) |
| BMX non-receptor tyrosine kinase/Cytoplasmic tyrosine-protein kinase BMX in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3834] [GtoPdb: 1942] [UniProtKB: P51813] | ||||||||
| ChEMBL | Inhibition of BMX (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| death associated protein kinase 1/Death-associated protein kinase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2558] [GtoPdb: 2002] [UniProtKB: P53355] | ||||||||
| ChEMBL | Inhibition of DAPK1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| death associated protein kinase 3/Death-associated protein kinase 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2468] [GtoPdb: 2004] [UniProtKB: O43293] | ||||||||
| ChEMBL | Inhibition of DAPK3 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| CDC like kinase 2/Dual specificity protein kinase CLK2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4225] [GtoPdb: 1991] [UniProtKB: P49760] | ||||||||
| ChEMBL | Inhibition of CLK2 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| dual specificity tyrosine phosphorylation regulated kinase 1A/Dual specificity tyrosine-phosphorylation-regulated kinase 1A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2292] [GtoPdb: 2009] [UniProtKB: Q13627] | ||||||||
| ChEMBL | Inhibition of DYRK1A (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| dual specificity tyrosine phosphorylation regulated kinase 1B/Dual specificity tyrosine-phosphorylation-regulated kinase 1B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5543] [GtoPdb: 2010] [UniProtKB: Q9Y463] | ||||||||
| ChEMBL | Inhibition of DYRK1B (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| dual specificity tyrosine phosphorylation regulated kinase 3/Dual specificity tyrosine-phosphorylation-regulated kinase 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4575] [GtoPdb: 2012] [UniProtKB: O43781] | ||||||||
| ChEMBL | Inhibition of DYRK3 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| dual specificity tyrosine phosphorylation regulated kinase 4/Dual specificity tyrosine-phosphorylation-regulated kinase 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075115] [GtoPdb: 2013] [UniProtKB: Q9NR20] | ||||||||
| ChEMBL | Inhibition of DYRK4 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| EPH receptor A1/Ephrin type-A receptor 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5810] [GtoPdb: 1821] [UniProtKB: P21709] | ||||||||
| ChEMBL | Inhibition of EPHA1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| EPH receptor A2/Ephrin type-A receptor 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2068] [GtoPdb: 1822] [UniProtKB: P29317] | ||||||||
| ChEMBL | Inhibition of EPHA2 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| EPH receptor A3/Ephrin type-A receptor 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4954] [GtoPdb: 1823] [UniProtKB: P29320] | ||||||||
| ChEMBL | Inhibition of EPHA3 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| EPH receptor A5/Ephrin type-A receptor 5 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3987] [GtoPdb: 1825] [UniProtKB: P54756] | ||||||||
| ChEMBL | Inhibition of EPHA5 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| EPH receptor A8/Ephrin type-A receptor 8 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4134] [GtoPdb: 1828] [UniProtKB: P29322] | ||||||||
| ChEMBL | Inhibition of EPHA8 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| EPH receptor B1/Ephrin type-B receptor 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5072] [GtoPdb: 1830] [UniProtKB: P54762] | ||||||||
| ChEMBL | Inhibition of EPHB1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| EPH receptor B2/Ephrin type-B receptor 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3290] [GtoPdb: 1831] [UniProtKB: P29323] | ||||||||
| ChEMBL | Inhibition of EPHB2 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| EPH receptor B3/Ephrin type-B receptor 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4901] [GtoPdb: 1832] [UniProtKB: P54753] | ||||||||
| ChEMBL | Inhibition of EPHB3 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| EPH receptor B4/Ephrin type-B receptor 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5147] [GtoPdb: 1833] [UniProtKB: P54760] | ||||||||
| ChEMBL | Inhibition of EPHB4 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| epidermal growth factor receptor/Epidermal growth factor receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL203] [GtoPdb: 1797] [UniProtKB: P00533] | ||||||||
| ChEMBL | Inhibition of EGFR (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| eukaryotic elongation factor 2 kinase/Eukaryotic elongation factor 2 kinase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5026] [GtoPdb: 2014] [UniProtKB: O00418] | ||||||||
| ChEMBL | Inhibition of EEF2K (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| fibroblast growth factor receptor 1/Fibroblast growth factor receptor 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3650] [GtoPdb: 1808] [UniProtKB: P11362] | ||||||||
| ChEMBL | Inhibition of FGFR1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| fibroblast growth factor receptor 2/Fibroblast growth factor receptor 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4142] [GtoPdb: 1809] [UniProtKB: P21802] | ||||||||
| ChEMBL | Inhibition of FGFR2 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| fibroblast growth factor receptor 3/Fibroblast growth factor receptor 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2742] [GtoPdb: 1810] [UniProtKB: P22607] | ||||||||
| ChEMBL | Inhibition of FGFR3 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| fibroblast growth factor receptor 4/Fibroblast growth factor receptor 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3973] [GtoPdb: 1811] [UniProtKB: P22455] | ||||||||
| ChEMBL | Inhibition of FGFR4 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| glycogen synthase kinase 3 alpha/Glycogen synthase kinase-3 alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2850] [GtoPdb: 2029] [UniProtKB: P49840] | ||||||||
| ChEMBL | Inhibition of GSK3A (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| glycogen synthase kinase 3 beta/Glycogen synthase kinase-3 beta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL262] [GtoPdb: 2030] [UniProtKB: P49841] | ||||||||
| ChEMBL | Inhibition of GSK3B (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| beta adrenergic receptor kinase 2/G protein-coupled receptor kinase 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075166] [GtoPdb: 1467] [UniProtKB: P35626] | ||||||||
| ChEMBL | Inhibition of ADRBK2 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| G protein-coupled receptor kinase 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5861] [GtoPdb: 1468] [UniProtKB: P32298] | ||||||||
| ChEMBL | Inhibition of GRK4 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| G protein-coupled receptor kinase 5 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5678] [GtoPdb: 1469] [UniProtKB: P34947] | ||||||||
| ChEMBL | Inhibition of GRK5 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| G protein-coupled receptor kinase 6 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6144] [GtoPdb: 1470] [UniProtKB: P43250] | ||||||||
| ChEMBL | Inhibition of GRK6 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| MET proto-oncogene, receptor tyrosine kinase/Hepatocyte growth factor receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3717] [GtoPdb: 1815] [UniProtKB: P08581] | ||||||||
| ChEMBL | Inhibition of MET (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| homeodomain interacting protein kinase 1/Homeodomain-interacting protein kinase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5427] [GtoPdb: 2033] [UniProtKB: Q86Z02] | ||||||||
| ChEMBL | Inhibition of HIPK1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| homeodomain interacting protein kinase 2/Homeodomain-interacting protein kinase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4576] [GtoPdb: 2034] [UniProtKB: Q9H2X6] | ||||||||
| ChEMBL | Inhibition of HIPK2 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| homeodomain interacting protein kinase 4/Homeodomain-interacting protein kinase 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075167] [GtoPdb: 2036] [UniProtKB: Q8NE63] | ||||||||
| ChEMBL | Inhibition of HIPK4 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| component of inhibitor of nuclear factor kappa B kinase complex/Inhibitor of nuclear factor kappa-B kinase subunit alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3476] [GtoPdb: 1989] [UniProtKB: O15111] | ||||||||
| ChEMBL | Inhibition of CHUK (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| inhibitor of nuclear factor kappa B kinase subunit beta/Inhibitor of nuclear factor kappa-B kinase subunit beta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1991] [GtoPdb: 2039] [UniProtKB: O14920] | ||||||||
| ChEMBL | Inhibition of IKBKB (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| inhibitor of nuclear factor kappa B kinase subunit epsilon/Inhibitor of nuclear factor kappa-B kinase subunit epsilon in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3529] [GtoPdb: 2040] [UniProtKB: Q14164] | ||||||||
| ChEMBL | Inhibition of IKBKE (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| Insulin-like growth factor I receptor/Insulin-like growth factor 1 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1957] [GtoPdb: 1801] [UniProtKB: P08069] | ||||||||
| ChEMBL | Inhibition of IGF1R (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| Insulin receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1981] [GtoPdb: 1800] [UniProtKB: P06213] | ||||||||
| ChEMBL | Inhibition of INSR (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| interleukin 1 receptor associated kinase 4/Interleukin-1 receptor-associated kinase 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3778] [GtoPdb: 2045] [UniProtKB: Q9NWZ3] | ||||||||
| ChEMBL | Inhibition of IRAK4 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| leucine rich repeat kinase 2/Leucine-rich repeat serine/threonine-protein kinase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075104] [GtoPdb: 2059] [UniProtKB: Q5S007] | ||||||||
| ChEMBL | Inhibition of LRRK2 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| leukocyte receptor tyrosine kinase/Leukocyte tyrosine kinase receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5627] [GtoPdb: 1838] [UniProtKB: P29376] | ||||||||
| ChEMBL | Inhibition of LTK (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| colony stimulating factor 1 receptor/Macrophage colony-stimulating factor 1 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1844] [GtoPdb: 1806] [UniProtKB: P07333] | ||||||||
| ChEMBL | Inhibition of CSF1R (unknown origin) expressed in mouse NFS-60 cells assessed as inhibition of CSF1-CSF1R dependent cell proliferation incubated for 3 days by ATPlite 1step Luminescence Assay reagent based assay | B | 6.59 | pIC50 | 260 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| ChEMBL | Inhibition of CSF1R (unknown origin) expressed in mouse EOC 20 cells assessed as inhibition of CSF1-CSF1R dependent cell proliferation incubated for 3 days by ATPlite 1step Luminescence Assay reagent based assay | B | 6.96 | pIC50 | 110 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| ChEMBL | Biochemical Assay: In one assay the biochemical activity IC50 values are determined with respect to inhibition of Fms kinase activity, where inhibition of phosphorylation of a peptide substrate is measured as a function of compound concentration. Compounds to be tested, dissolved in DMSO (1 uL), are added to a white 384-well plate (Costar #3705). Working stocks of Fms kinase (Invitrogen #PV3249), biotin-(E4Y)10 substrate (Upstate Biotech, Cat#12-440), and ATP (Sigma, Cat#A-3377) are prepared in 25 mM Hepes pH 7.5, 0.5 mM MgCl2, 2 mM MnCl2, 2 mM DTT, 0.01% BSA, and 0.01% Tween-20. All components are added to the 384-well plate for a final concentration of 1 ng/well Fms, 30 nM biotin-(E4Y)10 (Upstate Biotechnology) and 100 uM ATP in a volume of 20 uL. Each sample is at 5% DMSO. The plate is then incubated for 20 minutes at 30 C. Just before use, working stocks of donor and acceptor beads from the AlphaScreen PY20 Detection Kit (PerkinElmer, Cat#676601M) are prepared in 25 mM Hepes pH 7.5. | B | 7 | pIC50 | <100 | nM | IC50 | US-9096593-B2. Compounds and methods for kinase modulation, and indications therefor (2015) |
| ChEMBL | Biochemical Assay: In one assay the biochemical activity IC50 values are determined with respect to inhibition of Fms kinase activity, where inhibition of phosphorylation of a peptide substrate is measured as a function of compound concentration. Compounds to be tested, dissolved in DMSO (1 uL), are added to a white 384-well plate (Costar #3705). Working stocks of Fms kinase (Invitrogen #PV3249), biotin-(E4Y)10 substrate (Upstate Biotech, Cat#12-440), and ATP (Sigma, Cat#A-3377) are prepared in 25 mM Hepes pH 7.5, 0.5 mM MgCl2, 2 mM MnCl2, 2 mM DTT, 0.01% BSA, and 0.01% Tween-20. All components are added to the 384-well plate for a final concentration of 1 ng/well Fms, 30 nM biotin-(E4Y)10 (Upstate Biotechnology) and 100 uM ATP in a volume of 20 uL. Each sample is at 5% DMSO. The plate is then incubated for 20 minutes at 30 C. Just before use, working stocks of donor and acceptor beads from the AlphaScreen PY20 Detection Kit (PerkinElmer, Cat#676601M) are prepared in 25 mM Hepes pH 7.5. | B | 7 | pIC50 | <100 | nM | IC50 | US-9096593-B2. Compounds and methods for kinase modulation, and indications therefor (2015) |
| ChEMBL | Affinity Phenotypic Cellular interaction (THP-1 CSF1R phosphor-Tyr assay (CSF1R autophosphorylation in human acute monocytic leukemia cell line THP-1)) EUB0000697a CSF1R | B | 7.24 | pIC50 | 58 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomics Library wave 3 |
| ChEMBL | Inhibition of CSF1R autophosphorylation in human THP-1 cells | B | 7.24 | pIC50 | 58 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| ChEMBL | Inhibition of CSF1R (unknown origin) | B | 7.8 | pIC50 | 16 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| ChEMBL | Inhibition of CSF1R (unknown origin) in presence of 100 uM ATP by enzymatic assay | B | 7.8 | pIC50 | 16 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| ChEMBL | Affinity Biochemical interaction (Enzymatic inhibition assay (100 µM ATP)) EUB0000697a CSF1R | B | 7.8 | pIC50 | 16 | nM | IC50 | Affinity Biochemical Literature for EUbOPEN Chemogenomics Library wave 3 |
| ChEMBL | Inhibition of human CSF1R by discoverX kinome scan assay | B | 7.8 | pIC50 | 16 | nM | IC50 | Eur J Med Chem (2023) 245: 114884-114884 [PMID:36335744] |
| colony stimulating factor 1 receptor/Macrophage colony-stimulating factor 1 receptor in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5570] [GtoPdb: 1806] [UniProtKB: P09581] | ||||||||
| ChEMBL | Inhibition of CSF1R autophosphorylation in mouse RAW264.7 cells measured after 4 hrs by Western blot analysis | B | 7.59 | pIC50 | 26 | nM | IC50 | Eur J Med Chem (2023) 245: 114884-114884 [PMID:36335744] |
| macrophage stimulating 1 receptor/Macrophage-stimulating protein receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2689] [GtoPdb: 1816] [UniProtKB: Q04912] | ||||||||
| ChEMBL | Inhibition of MST1R (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| MAPK activated protein kinase 2/MAP kinase-activated protein kinase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2208] [GtoPdb: 2094] [UniProtKB: P49137] | ||||||||
| ChEMBL | Inhibition of MAPKAPK2 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| MAPK activated protein kinase 3/MAP kinase-activated protein kinase 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4670] [GtoPdb: 2095] [UniProtKB: Q16644] | ||||||||
| ChEMBL | Inhibition of MAPKAPK3 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| MAPK activated protein kinase 5/MAP kinase-activated protein kinase 5 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3094] [GtoPdb: 2096] [UniProtKB: Q8IW41] | ||||||||
| ChEMBL | Inhibition of MAPKAPK5 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| microtubule affinity regulating kinase 3/MAP/microtubule affinity-regulating kinase 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5600] [GtoPdb: 2099] [UniProtKB: P27448] | ||||||||
| ChEMBL | Inhibition of MARK3 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| microtubule affinity regulating kinase 4/MAP/microtubule affinity-regulating kinase 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5754] [GtoPdb: 2100] [UniProtKB: Q96L34] | ||||||||
| ChEMBL | Inhibition of MARK4 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| KIT proto-oncogene, receptor tyrosine kinase/Mast/stem cell growth factor receptor Kit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1936] [GtoPdb: 1805] [UniProtKB: P10721] | ||||||||
| ChEMBL | Inhibition of endogenous KIT in human M-07e cells assessed as inhibition of SCF-KIT dependent cell proliferation incubated for 3 days by ATPlite 1step Luminescence Assay reagent based assay | B | 5.34 | pIC50 | 4600 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| ChEMBL | Selectivity interaction (BCR-KIT fusion dependent proliferation of Ba/F3 cells) EUB0000697a KIT | B | 5.57 | pIC50 | 2700 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
| ChEMBL | Inhibition of KIT (unknown origin) in presence of ATP by enzymatic assay | B | 6.07 | pIC50 | 860 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| ChEMBL | Inhibition of KIT (unknown origin) | B | 6.07 | pIC50 | 860 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| ChEMBL | Selectivity interaction (SelectScreen (Invitrogen, enzymatic assay with 100 µM ATP)) EUB0000697a KIT | B | 6.07 | pIC50 | 860 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
| GtoPdb | Binned IC50 value from patent data | - | 7 | pIC50 | >100 | nM | IC50 | US9096593B2. Compounds and methods for kinase modulation, and indications therefor (2015) |
| ChEMBL | Biochemical Assay: In one assay the biochemical activity IC50 values are determined with respect to inhibition of c-Kit kinase activity, where inhibition of phosphorylation of a peptide substrate is measured as a function of compound concentration. Compounds to be tested are dissolved in DMSO to a concentration of 20 mM. These are diluted 30 uL into 120 uL of DMSO (4 mM) and 1 uL is added to an assay plate. These are then serially diluted 1:2 (50 uL to 100 uL DMSO) for a total of 8 points. Plates are prepared such that each kinase reaction is 20 uL in 1x kinase buffer (25 mM HEPES, pH 7.5, 2 mM MgCl2, 2 mM MnCl2, 0.01% Tween-20, 1 mM DTT, 0.01% BSA), 5% DMSO and 100 uM ATP. Substrate is 30 nM biotin-(E4Y)10 (Millipore). C-kit kinase (obtained from Millipore (#14-559) or is prepared as described in U.S. Patent Application Publication Number 2009/0076046, the disclosure of which is hereby incorporated by reference as it relates to this assay) is at 0.75 ng per sample. | B | 7 | pIC50 | >100 | nM | IC50 | US-9096593-B2. Compounds and methods for kinase modulation, and indications therefor (2015) |
| ChEMBL | Biochemical Assay: In one assay the biochemical activity IC50 values are determined with respect to inhibition of c-Kit kinase activity, where inhibition of phosphorylation of a peptide substrate is measured as a function of compound concentration. Compounds to be tested are dissolved in DMSO to a concentration of 20 mM. These are diluted 30 uL into 120 uL of DMSO (4 mM) and 1 uL is added to an assay plate. These are then serially diluted 1:2 (50 uL to 100 uL DMSO) for a total of 8 points. Plates are prepared such that each kinase reaction is 20 uL in 1x kinase buffer (25 mM HEPES, pH 7.5, 2 mM MgCl2, 2 mM MnCl2, 0.01% Tween-20, 1 mM DTT, 0.01% BSA), 5% DMSO and 100 uM ATP. Substrate is 30 nM biotin-(E4Y)10 (Millipore). C-kit kinase (obtained from Millipore (#14-559) or is prepared as described in U.S. Patent Application Publication Number 2009/0076046, the disclosure of which is hereby incorporated by reference as it relates to this assay) is at 0.75 ng per sample. | B | 7 | pIC50 | >100 | nM | IC50 | US-9096593-B2. Compounds and methods for kinase modulation, and indications therefor (2015) |
| maternal embryonic leucine zipper kinase/Maternal embryonic leucine zipper kinase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4578] [GtoPdb: 2102] [UniProtKB: Q14680] | ||||||||
| ChEMBL | Inhibition of MELK (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| megakaryocyte-associated tyrosine kinase/Megakaryocyte-associated tyrosine-protein kinase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4175] [GtoPdb: 2101] [UniProtKB: P42679] | ||||||||
| ChEMBL | Inhibition of MATK (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| misshapen like kinase 1/Misshapen-like kinase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5518] [GtoPdb: 2103] [UniProtKB: Q8N4C8] | ||||||||
| ChEMBL | Inhibition of MINK1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| mitogen-activated protein kinase 1/Mitogen-activated protein kinase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4040] [GtoPdb: 1495] [UniProtKB: P28482] | ||||||||
| ChEMBL | Inhibition of MAPK1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| mitogen-activated protein kinase 12/Mitogen-activated protein kinase 12 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4674] [GtoPdb: 1501] [UniProtKB: P53778] | ||||||||
| ChEMBL | Inhibition of MAPK12 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| mitogen-activated protein kinase 13/Mitogen-activated protein kinase 13 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2939] [GtoPdb: 1502] [UniProtKB: O15264] | ||||||||
| ChEMBL | Inhibition of MAPK13 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| mitogen-activated protein kinase 3/Mitogen-activated protein kinase 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3385] [GtoPdb: 1494] [UniProtKB: P27361] | ||||||||
| ChEMBL | Inhibition of MAPK3 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| mitogen-activated protein kinase kinase kinase kinase 2/Mitogen-activated protein kinase kinase kinase kinase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5330] [GtoPdb: 2086] [UniProtKB: Q12851] | ||||||||
| ChEMBL | Inhibition of MAP4K2 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| mitogen-activated protein kinase kinase kinase kinase 4/Mitogen-activated protein kinase kinase kinase kinase 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6166] [GtoPdb: 2088] [UniProtKB: O95819] | ||||||||
| ChEMBL | Inhibition of MAP4K4 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| mitogen-activated protein kinase kinase kinase kinase 5/Mitogen-activated protein kinase kinase kinase kinase 5 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4852] [GtoPdb: 2089] [UniProtKB: Q9Y4K4] | ||||||||
| ChEMBL | Inhibition of MAP4K5 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| neurotrophic receptor tyrosine kinase 3/NT-3 growth factor receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5608] [GtoPdb: 1819] [UniProtKB: Q16288] | ||||||||
| ChEMBL | Inhibition of NTRK3 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| phosphatidylinositol 3-kinase catalytic subunit type 3/Phosphatidylinositol 3-kinase catalytic subunit type 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075165] [GtoPdb: 2152] [UniProtKB: Q8NEB9] | ||||||||
| ChEMBL | Inhibition of PIK3C3 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma/Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3267] [GtoPdb: 2156] [UniProtKB: P48736] | ||||||||
| ChEMBL | Inhibition of PIK3CG (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| phosphatidylinositol 4-kinase beta/Phosphatidylinositol 4-kinase beta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3268] [GtoPdb: 2149] [UniProtKB: Q9UBF8] | ||||||||
| ChEMBL | Inhibition of PI4KB (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| phosphorylase kinase catalytic subunit gamma 2/Phosphorylase b kinase gamma catalytic chain, liver/testis isoform in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2349] [GtoPdb: 2147] [UniProtKB: P15735] | ||||||||
| ChEMBL | Inhibition of PHKG2 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| phosphorylase kinase catalytic subunit gamma 1/Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4004] [GtoPdb: 2145] [UniProtKB: Q16816] | ||||||||
| ChEMBL | Inhibition of PHKG1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| phosphoinositide-3-kinase regulatory subunit 1/phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/PI3-kinase p110-alpha/p85-alpha in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2111367] [GtoPdb: 2503, 2153] [UniProtKB: P27986, P42336] | ||||||||
| ChEMBL | Inhibition of PIK3CA/PIK3R1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta/phosphoinositide-3-kinase regulatory subunit 1/PI3-kinase p110-delta/p85-alpha in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2111432] [GtoPdb: 2155, 2503] [UniProtKB: O00329, P27986] | ||||||||
| ChEMBL | Inhibition of PIK3CD/PIK3R1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| platelet derived growth factor receptor alpha/Platelet-derived growth factor receptor alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2007] [GtoPdb: 1803] [UniProtKB: P16234] | ||||||||
| ChEMBL | Inhibition of PDGFRA (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| platelet derived growth factor receptor beta/Platelet-derived growth factor receptor beta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1913] [GtoPdb: 1804] [UniProtKB: P09619] | ||||||||
| ChEMBL | Inhibition of PDGFRB (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| protein kinase C alpha/Protein kinase C alpha type in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL299] [GtoPdb: 1482] [UniProtKB: P17252] | ||||||||
| ChEMBL | Inhibition of PRKCA (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| protein kinase C beta/Protein kinase C beta type in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3045] [GtoPdb: 1483] [UniProtKB: P05771] | ||||||||
| ChEMBL | Inhibition of PRKCB1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| ChEMBL | Inhibition of PRKCB2 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| protein kinase C delta/Protein kinase C delta type in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2996] [GtoPdb: 1485] [UniProtKB: Q05655] | ||||||||
| ChEMBL | Inhibition of PRKCD (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| protein kinase C epsilon/Protein kinase C epsilon type in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3582] [GtoPdb: 1486] [UniProtKB: Q02156] | ||||||||
| ChEMBL | Inhibition of PRKCE (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| protein kinase C eta/Protein kinase C eta type in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3616] [GtoPdb: 1487] [UniProtKB: P24723] | ||||||||
| ChEMBL | Inhibition of PRKCH (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| protein kinase C gamma/Protein kinase C gamma type in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2938] [GtoPdb: 1484] [UniProtKB: P05129] | ||||||||
| ChEMBL | Inhibition of PRKCG (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| protein kinase C iota/Protein kinase C iota type in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2598] [GtoPdb: 1490] [UniProtKB: P41743] | ||||||||
| ChEMBL | Inhibition of PRKCI (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| protein kinase C theta/Protein kinase C theta type in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3920] [GtoPdb: 1488] [UniProtKB: Q04759] | ||||||||
| ChEMBL | Inhibition of PRKCQ (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| protein kinase C zeta/Protein kinase C zeta type in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3438] [GtoPdb: 1491] [UniProtKB: Q05513] | ||||||||
| ChEMBL | Inhibition of PRKCZ (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| protein tyrosine kinase 2 beta/Protein-tyrosine kinase 2-beta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5469] [GtoPdb: 2181] [UniProtKB: Q14289] | ||||||||
| ChEMBL | Inhibition of PTK2B (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| ret proto-oncogene/Proto-oncogene tyrosine-protein kinase receptor Ret in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2041] [GtoPdb: 2185] [UniProtKB: P07949] | ||||||||
| ChEMBL | Inhibition of RET (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| ChEMBL | Inhibition of RET V804L mutant (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| ChEMBL | Inhibition of RET Y791F mutant (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| SRC proto-oncogene, non-receptor tyrosine kinase/Proto-oncogene tyrosine-protein kinase Src in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL267] [GtoPdb: 2206] [UniProtKB: P12931] | ||||||||
| ChEMBL | Inhibition of SRC (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| AKT serine/threonine kinase 1/RAC-alpha serine/threonine-protein kinase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4282] [GtoPdb: 1479] [UniProtKB: P31749] | ||||||||
| ChEMBL | Inhibition of AKT1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| AKT serine/threonine kinase 2/RAC-beta serine/threonine-protein kinase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2431] [GtoPdb: 1480] [UniProtKB: P31751] | ||||||||
| ChEMBL | Inhibition of AKT2 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| AKT serine/threonine kinase 3/RAC-gamma serine/threonine-protein kinase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4816] [GtoPdb: 2286] [UniProtKB: Q9Y243] | ||||||||
| ChEMBL | Inhibition of AKT3 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| fms related receptor tyrosine kinase 3/Receptor-type tyrosine-protein kinase FLT3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1974] [GtoPdb: 1807] [UniProtKB: P36888] | ||||||||
| ChEMBL | Selectivity interaction (FLT3-ITD dependent proliferation of Ba/F3 cells) EUB0000697a FLT3 | B | 5 | pIC50 | >10000 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
| ChEMBL | Inhibition of FLT3-ITD (unknown origin) expressed in mouse BaF3 cells assessed as inhibition of FLT3-ITD dependent cell proliferation incubated for 3 days by ATPlite 1step Luminescence Assay reagent based assay | B | 5 | pIC50 | >10000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| ChEMBL | Inhibition of FLT3 (unknown origin) expressed in mouse BaF3 cells assessed as inhibition of FLT3 ligand-FLT3 dependent cell proliferation incubated for 3 days by ATPlite 1step Luminescence Assay reagent based assay | B | 5 | pIC50 | >10000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| ChEMBL | Selectivity interaction (SelectScreen (Invitrogen, enzymatic assay with 100 µM ATP)) EUB0000697a FLT3 | B | 6.41 | pIC50 | 390 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
| ChEMBL | Inhibition of FLT3 (unknown origin) | B | 6.41 | pIC50 | 390 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| ChEMBL | Inhibition of FLT3 (unknown origin) in presence of ATP by enzymatic assay | B | 6.41 | pIC50 | 390 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| erb-b2 receptor tyrosine kinase 2/Receptor tyrosine-protein kinase erbB-2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1824] [GtoPdb: 2019] [UniProtKB: P04626] | ||||||||
| ChEMBL | Inhibition of ERBB2 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| erb-b2 receptor tyrosine kinase 4/Receptor tyrosine-protein kinase erbB-4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3009] [GtoPdb: 1799] [UniProtKB: Q15303] | ||||||||
| ChEMBL | Inhibition of ERBB4 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| Rho associated coiled-coil containing protein kinase 1/Rho-associated protein kinase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3231] [GtoPdb: 1503] [UniProtKB: Q13464] | ||||||||
| ChEMBL | Inhibition of ROCK1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| Rho associated coiled-coil containing protein kinase 2/Rho-associated protein kinase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2973] [GtoPdb: 1504] [UniProtKB: O75116] | ||||||||
| ChEMBL | Inhibition of ROCK2 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| G protein-coupled receptor kinase 7/Rhodopsin kinase GRK7 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075133] [GtoPdb: 1471] [UniProtKB: Q8WTQ7] | ||||||||
| ChEMBL | Inhibition of GRK7 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| ribosomal protein S6 kinase A1/Ribosomal protein S6 kinase alpha-1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2553] [GtoPdb: 1527] [UniProtKB: Q15418] | ||||||||
| ChEMBL | Inhibition of RPS6KA1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| ribosomal protein S6 kinase A2/Ribosomal protein S6 kinase alpha-2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3906] [GtoPdb: 1529] [UniProtKB: Q15349] | ||||||||
| ChEMBL | Inhibition of RPS6KA2 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| ribosomal protein S6 kinase A3/Ribosomal protein S6 kinase alpha-3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2345] [GtoPdb: 1528] [UniProtKB: P51812] | ||||||||
| ChEMBL | Inhibition of RPS6KA3 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| ribosomal protein S6 kinase A4/Ribosomal protein S6 kinase alpha-4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3125] [GtoPdb: 1524] [UniProtKB: O75676] | ||||||||
| ChEMBL | Inhibition of RPS6KA4 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| ribosomal protein S6 kinase A5/Ribosomal protein S6 kinase alpha-5 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4237] [GtoPdb: 1523] [UniProtKB: O75582] | ||||||||
| ChEMBL | Inhibition of RPS6KA5 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| ribosomal protein S6 kinase A6/Ribosomal protein S6 kinase alpha-6 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4924] [GtoPdb: 1530] [UniProtKB: Q9UK32] | ||||||||
| ChEMBL | Inhibition of RPS6KA6 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| ribosomal protein S6 kinase B1/Ribosomal protein S6 kinase beta-1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4501] [GtoPdb: 1525] [UniProtKB: P23443] | ||||||||
| ChEMBL | Inhibition of RPS6KB1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| serine/threonine kinase 25/Serine/threonine-protein kinase 25 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5552] [GtoPdb: 2218] [UniProtKB: O00506] | ||||||||
| ChEMBL | Inhibition of STK25 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| serine/threonine kinase 4/Serine/threonine-protein kinase 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4598] [GtoPdb: 2225] [UniProtKB: Q13043] | ||||||||
| ChEMBL | Inhibition of STK4 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| BR serine/threonine kinase 1/Serine/threonine-protein kinase BRSK1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5650] [GtoPdb: 1946] [UniProtKB: Q8TDC3] | ||||||||
| ChEMBL | Inhibition of BRSK1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| checkpoint kinase 1/Serine/threonine-protein kinase Chk1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4630] [GtoPdb: 1987] [UniProtKB: O14757] | ||||||||
| ChEMBL | Inhibition of CHEK1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| protein kinase D1/Serine/threonine-protein kinase D1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3863] [GtoPdb: 1489] [UniProtKB: Q15139] | ||||||||
| ChEMBL | Inhibition of PRKD1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| protein kinase D2/Serine/threonine-protein kinase D2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4900] [GtoPdb: 2173] [UniProtKB: Q9BZL6] | ||||||||
| ChEMBL | Inhibition of PRKD2 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| protein kinase D3/Serine/threonine-protein kinase D3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2595] [GtoPdb: 2174] [UniProtKB: O94806] | ||||||||
| ChEMBL | Inhibition of PRKCN (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| microtubule affinity regulating kinase 1/Serine/threonine-protein kinase MARK1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5940] [GtoPdb: 2097] [UniProtKB: Q9P0L2] | ||||||||
| ChEMBL | Inhibition of MARK1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| microtubule affinity regulating kinase 2/Serine/threonine-protein kinase MARK2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3831] [GtoPdb: 2098] [UniProtKB: Q7KZI7] | ||||||||
| ChEMBL | Inhibition of MARK2 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| CDC42 binding protein kinase alpha/Serine/threonine-protein kinase MRCK alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4516] [GtoPdb: 1507] [UniProtKB: Q5VT25] | ||||||||
| ChEMBL | Inhibition of CDC42_BPA (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| CDC42 binding protein kinase beta/Serine/threonine-protein kinase MRCK beta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5052] [GtoPdb: 1508] [UniProtKB: Q9Y5S2] | ||||||||
| ChEMBL | Inhibition of CDC42_BPB (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| mechanistic target of rapamycin kinase/Serine/threonine-protein kinase mTOR in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2842] [GtoPdb: 2109] [UniProtKB: P42345] | ||||||||
| ChEMBL | Inhibition of FRAP1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| protein kinase N1/Serine/threonine-protein kinase N1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3384] [GtoPdb: 1520] [UniProtKB: Q16512] | ||||||||
| ChEMBL | Inhibition of PKN1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| NIMA related kinase 1/Serine/threonine-protein kinase Nek1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5855] [GtoPdb: 2114] [UniProtKB: Q96PY6] | ||||||||
| ChEMBL | Inhibition of NEK1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| NIMA related kinase 2/Serine/threonine-protein kinase Nek2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3835] [GtoPdb: 2117] [UniProtKB: P51955] | ||||||||
| ChEMBL | Inhibition of NEK2 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| NIMA related kinase 6/Serine/threonine-protein kinase Nek6 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4309] [GtoPdb: 2121] [UniProtKB: Q9HC98] | ||||||||
| ChEMBL | Inhibition of NEK6 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| NIMA related kinase 9/Serine/threonine-protein kinase Nek9 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5257] [GtoPdb: 2124] [UniProtKB: Q8TD19] | ||||||||
| ChEMBL | Inhibition of NEK9 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| p21 (RAC1) activated kinase 2/Serine/threonine-protein kinase PAK 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4487] [GtoPdb: 2134] [UniProtKB: Q13177] | ||||||||
| ChEMBL | Inhibition of PAK2 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| p21 (RAC1) activated kinase 3/Serine/threonine-protein kinase PAK 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2999] [GtoPdb: 2135] [UniProtKB: O75914] | ||||||||
| ChEMBL | Inhibition of PAK3 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| p21 (RAC1) activated kinase 4/Serine/threonine-protein kinase PAK 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4482] [GtoPdb: 2136] [UniProtKB: O96013] | ||||||||
| ChEMBL | Inhibition of PAK4 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| p21 (RAC1) activated kinase 5/Serine/threonine-protein kinase PAK 5 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4524] [GtoPdb: 2138] [UniProtKB: Q9P286] | ||||||||
| ChEMBL | Inhibition of PAK7 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| p21 (RAC1) activated kinase 6/Serine/threonine-protein kinase PAK 6 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4311] [GtoPdb: 2137] [UniProtKB: Q9NQU5] | ||||||||
| ChEMBL | Inhibition of PAK6 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| Pim-1 proto-oncogene, serine/threonine kinase/Serine/threonine-protein kinase pim-1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2147] [GtoPdb: 2158] [UniProtKB: P11309] | ||||||||
| ChEMBL | Inhibition of PIM1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| Pim-2 proto-oncogene, serine/threonine kinase/Serine/threonine-protein kinase pim-2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4523] [GtoPdb: 2159] [UniProtKB: Q9P1W9] | ||||||||
| ChEMBL | Inhibition of PIM2 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| polo like kinase 1/Serine/threonine-protein kinase PLK1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3024] [GtoPdb: 2168] [UniProtKB: P53350] | ||||||||
| ChEMBL | Inhibition of PLK1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| polo like kinase 2/Serine/threonine-protein kinase PLK2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5938] [GtoPdb: 2169] [UniProtKB: Q9NYY3] | ||||||||
| ChEMBL | Inhibition of PLK2 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| polo like kinase 3/Serine/threonine-protein kinase PLK3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4897] [GtoPdb: 2170] [UniProtKB: Q9H4B4] | ||||||||
| ChEMBL | Inhibition of PLK3 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| serum/glucocorticoid regulated kinase 1/Serine/threonine-protein kinase Sgk1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2343] [GtoPdb: 1534] [UniProtKB: O00141] | ||||||||
| ChEMBL | Inhibition of SGK (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| serum/glucocorticoid regulated kinase 2/Serine/threonine-protein kinase Sgk2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5794] [GtoPdb: 1535] [UniProtKB: Q9HBY8] | ||||||||
| ChEMBL | Inhibition of SGK2 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| serum/glucocorticoid regulated kinase family member 3/Serine/threonine-protein kinase Sgk3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6186] [GtoPdb: 1536] [UniProtKB: Q96BR1] | ||||||||
| ChEMBL | Inhibition of SGKL (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| salt inducible kinase 2/Serine/threonine-protein kinase SIK2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5699] [GtoPdb: 2198] [UniProtKB: Q9H0K1] | ||||||||
| ChEMBL | Inhibition of SNF1LK2 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| TANK binding kinase 1/Serine/threonine-protein kinase TBK1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5408] [GtoPdb: 2237] [UniProtKB: Q9UHD2] | ||||||||
| ChEMBL | Inhibition of TBK1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| sphingosine kinase 1/Sphingosine kinase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4394] [GtoPdb: 2204] [UniProtKB: Q9NYA1] | ||||||||
| ChEMBL | Inhibition of SPHK1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| SRC kinase signaling inhibitor 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2150836] [UniProtKB: Q9C0H9] | ||||||||
| ChEMBL | Inhibition of SRCN1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| SRSF protein kinase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4375] [GtoPdb: 2208] [UniProtKB: Q96SB4] | ||||||||
| ChEMBL | Inhibition of SRPK1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| SRSF protein kinase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5668] [GtoPdb: 2209] [UniProtKB: P78362] | ||||||||
| ChEMBL | Inhibition of SRPK2 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| testis specific serine kinase 1B/Testis-specific serine/threonine-protein kinase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6003] [GtoPdb: 2257] [UniProtKB: Q9BXA7] | ||||||||
| ChEMBL | Inhibition of STK22D (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| testis specific serine kinase 2/Testis-specific serine/threonine-protein kinase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6014] [GtoPdb: 2258] [UniProtKB: Q96PF2] | ||||||||
| ChEMBL | Inhibition of STK22B (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| ABL proto-oncogene 1, non-receptor tyrosine kinase/Tyrosine-protein kinase ABL1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1862] [GtoPdb: 1923] [UniProtKB: P00519] | ||||||||
| ChEMBL | Inhibition of ABL1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| ABL proto-oncogene 2, non-receptor tyrosine kinase/Tyrosine-protein kinase ABL2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4014] [GtoPdb: 1924] [UniProtKB: P42684] | ||||||||
| ChEMBL | Inhibition of ABL2 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| BLK proto-oncogene, Src family tyrosine kinase/Tyrosine-protein kinase Blk in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2250] [GtoPdb: 1940] [UniProtKB: P51451] | ||||||||
| ChEMBL | Inhibition of BLK (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| Bruton tyrosine kinase/Tyrosine-protein kinase BTK in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5251] [GtoPdb: 1948] [UniProtKB: Q06187] | ||||||||
| ChEMBL | Inhibition of BTK (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| C-terminal Src kinase/Tyrosine-protein kinase CSK in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2634] [GtoPdb: 1994] [UniProtKB: P41240] | ||||||||
| ChEMBL | Inhibition of CSK (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| FER tyrosine kinase/Tyrosine-protein kinase Fer in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3982] [GtoPdb: 2022] [UniProtKB: P16591] | ||||||||
| ChEMBL | Inhibition of FER (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| FES proto-oncogene, tyrosine kinase/Tyrosine-protein kinase Fes/Fps in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5455] [GtoPdb: 2023] [UniProtKB: P07332] | ||||||||
| ChEMBL | Inhibition of FES (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| FGR proto-oncogene, Src family tyrosine kinase/Tyrosine-protein kinase Fgr in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4454] [GtoPdb: 2024] [UniProtKB: P09769] | ||||||||
| ChEMBL | Inhibition of FGR (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| fyn related Src family tyrosine kinase/Tyrosine-protein kinase FRK in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4223] [GtoPdb: 2025] [UniProtKB: P42685] | ||||||||
| ChEMBL | Inhibition of FRK (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| FYN proto-oncogene, Src family tyrosine kinase/Tyrosine-protein kinase Fyn in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1841] [GtoPdb: 2026] [UniProtKB: P06241] | ||||||||
| ChEMBL | Inhibition of FYN (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| HCK proto-oncogene, Src family tyrosine kinase/Tyrosine-protein kinase HCK in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3234] [GtoPdb: 2032] [UniProtKB: P08631] | ||||||||
| ChEMBL | Inhibition of HCK (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| IL2 inducible T cell kinase/Tyrosine-protein kinase ITK/TSK in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2959] [GtoPdb: 2046] [UniProtKB: Q08881] | ||||||||
| ChEMBL | Inhibition of ITK (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| Janus kinase 2/Tyrosine-protein kinase JAK2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2971] [GtoPdb: 2048] [UniProtKB: O60674] | ||||||||
| ChEMBL | Inhibition of JAK2 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| Janus kinase 3/Tyrosine-protein kinase JAK3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2148] [GtoPdb: 2049] [UniProtKB: P52333] | ||||||||
| ChEMBL | Inhibition of JAK3 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| LCK proto-oncogene, Src family tyrosine kinase/Tyrosine-protein kinase Lck in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL258] [GtoPdb: 2053] [UniProtKB: P06239] | ||||||||
| ChEMBL | Inhibition of LCK (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| LYN proto-oncogene, Src family tyrosine kinase/Tyrosine-protein kinase Lyn in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3905] [GtoPdb: 2060] [UniProtKB: P07948] | ||||||||
| ChEMBL | Inhibition of LYN_A (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| ChEMBL | Inhibition of LYN_B (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| MER proto-oncogene, tyrosine kinase/Tyrosine-protein kinase Mer in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5331] [GtoPdb: 1837] [UniProtKB: Q12866] | ||||||||
| ChEMBL | Inhibition of MERTK (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| TYRO3 protein tyrosine kinase/Tyrosine-protein kinase receptor TYRO3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5314] [GtoPdb: 1836] [UniProtKB: Q06418] | ||||||||
| ChEMBL | Inhibition of TYRO3 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| AXL receptor tyrosine kinase/Tyrosine-protein kinase receptor UFO in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4895] [GtoPdb: 1835] [UniProtKB: P30530] | ||||||||
| ChEMBL | Inhibition of AXL (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| spleen associated tyrosine kinase/Tyrosine-protein kinase SYK in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2599] [GtoPdb: 2230] [UniProtKB: P43405] | ||||||||
| ChEMBL | Inhibition of SYK (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| YES proto-oncogene 1, Src family tyrosine kinase/Tyrosine-protein kinase Yes in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2073] [GtoPdb: 2284] [UniProtKB: P07947] | ||||||||
| ChEMBL | Inhibition of YES1 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| zeta chain of T cell receptor associated protein kinase 70/Tyrosine-protein kinase ZAP-70 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2803] [GtoPdb: 2285] [UniProtKB: P43403] | ||||||||
| ChEMBL | Inhibition of ZAP70 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| kinase insert domain receptor/Vascular endothelial growth factor receptor 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL279] [GtoPdb: 1813] [UniProtKB: P35968] | ||||||||
| ChEMBL | Selectivity interaction (SelectScreen (Invitrogen, enzymatic assay with 100 µM ATP)) EUB0000697a KDR | B | 5.96 | pIC50 | 1100 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
| ChEMBL | Inhibition of KDR (unknown origin) | B | 5.96 | pIC50 | 1100 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
| fms related receptor tyrosine kinase 4/Vascular endothelial growth factor receptor 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1955] [GtoPdb: 1814] [UniProtKB: P35916] | ||||||||
| ChEMBL | Inhibition of FLT4 (unknown origin) | B | 6 | pIC50 | >1000 | nM | IC50 | Nat Commun (2019) 10: 3758-3758 [PMID:31434879] |
ChEMBL data shown on this page come from version 36:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]